Lv3
298 积分 2025-09-04 加入
Identifying developability risks for clinical progression of antibodies using high-throughput in vitro and in silico approaches
3个月前
已完结
Understanding the Impact of Methionine Oxidation on the Biological Functions of IgG1 Antibodies Using Hydrogen/Deuterium Exchange Mass Spectrometry
3个月前
已完结
Evaluation of heavy chain C‐terminal deletions on productivity and product quality of monoclonal antibodies in Chinese hamster ovary (CHO) cells
3个月前
已完结
Evaluation of Heavy-Chain C-Terminal Deletion on Product Quality and Pharmacokinetics of Monoclonal Antibodies
3个月前
已完结
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
4个月前
已完结
Safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of subcutaneous and intravenous ALXN1720 in healthy volunteers: a phase 1, randomized, double-blind, placebocontrolled, single and multiple ascending dose study (P1-5.016)
4个月前
已完结
Long-term stability of diluted solutions of the monoclonal antibody rituximab
4个月前
已完结
Characterization of the stability of a fully human monoclonal IgG after prolonged incubation at elevated temperature
4个月前
已完结
Developability Assessment During the Selection of Novel Therapeutic Antibodies
4个月前
已完结
Stability liabilities of biotherapeutic proteins: Early assessment as mitigation strategy
4个月前
已完结
皖公网安备34019202002308
